Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET

Clinical trial NCT06482307 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06482307
Sponsor: University Medical Center Groningen
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma (HNSCC)

Start date: 2025-05-01
Primary completion: 2026-02-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.